Giovanna DELLA PORTA | Projects

ASSEGNAZIONE PRIMA NOMINA DOTT.SSA DELLA PORTA GIOVANNA

The therapeutic efficacy of systemic drug-delivery vehicles depends on their ability to evade the immune system, cross the biological barriers of the body and localize at target tissues. White blood cells of the immune systemâ¿¿known as leukocytesâ¿¿possess all of these properties and exert their targeting ability through cellular membrane interactions.The research activity will be focused on the dev

Cofinanziamento per Assegno di Ricerca “Sviluppo di Membrane Avanzate per il Rilascio Controllato di Principi Attivi d’Interesse Farmaceutico Destinati alla Medicina Rigenerativa e alla Diagnosi Avanzata”

Microfluidic technology has achieved, recently, excellent results in term of liposome formation with a higher reproducible nano-sized vesicles, extremely narrow size distributions as well as nano-devices with SUV structure; furthermore, high protein loading and preserved biological activity were also reported.The goal of the research is to formulate with microfluidic technology a stable lipid na

Studio sperimentale di un sistema filtrante allestito con membrane prodotte con la tecnologia elettrospinning e/o filatura a bolla per filatrazione di buffy.coat umano recuperato da centro trasfusionale Numero Contratto

Studio sperimentale di un sistema filtrante allestito con membrane prodotte con la tecnologia elettrospinning e/o filatura a bolla per filatrazione di buffy.coat umano recuperato da centro trasfusionale Numero Contratto

Perspectives For Future Innovation in Tendon repair : (P4 FIT)

The advantages of transferring biological features from cells to synthetic nanoparticles for drug delivery purposes it has recently been reported.The aim of this project is to incorporate membrane proteins within the bilayer of biomimetic nanovesicles using a microfluidic-based platform.Indeed, microfluidics has offered a robust tool for the controlled synthesis of nanoparticles in a versatile